News for Medigene AG (MDG1.DE)

Published at

Jun 19, 2025 1:00 AM

by gurufocus.com

mixed

mixed

Satellos Bioscience Shareholders Elect Two New Board Members

[url="]Satellos Bioscience Inc.[/url] (TSX: MSCL, OTCQB: MSCLF) (”Satellos” or the ”Company”), a biotech company developing new small molecule therapeu

MSCL.V ICOTD MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Mar 25, 2025 2:00 PM

by gurufocus.com

positive

positive

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

PR NewswireBASEL, Switzerland, March 25, 2025 BASEL, Switzerland, March 25, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare com

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Feb 27, 2025 9:13 AM

by manilatimes.net

positive

positive

Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers

**media[551809,551810]**

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Feb 19, 2025 11:16 AM

by manilatimes.net

positive

positive

Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S.

**media[544113]**

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Feb 3, 2025 6:09 PM

by manilatimes.net

neutral

neutral

Medigene AG announces closing of its first SEPA tranche

**media[531040]**

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Dec 9, 2024 11:20 AM

by manilatimes.net

positive

positive

Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers

**media[486859]**

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Nov 12, 2024 4:24 PM

by investing.com

mixed

mixed

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update By Investing.com

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

MRK CVACN.MX CVAC BCS 5CV.DE MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Nov 8, 2024 3:49 PM

by manilatimes.net

positive

positive

Medigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024

**media[460375]**

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Oct 29, 2024 11:30 AM

by globenewswire.com

neutral

neutral

Medigene to Present at Upcoming Investor Conferences

Planegg/Martinsried, October 29, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Oct 24, 2024 6:02 PM

by seekingalpha.com

neutral

neutral

Medigene AG reports Q3 results (MDGEF:Pink Current Info)

Medigene AG reports Q3 2024 revenues of €1.4M, reiterates guidance for 2024, and holds €9.5M in cash and equivalents.

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Oct 17, 2024 11:30 AM

by globenewswire.com

positive

positive

Medigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024

Planegg/Martinsried, October 17, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Oct 16, 2024 11:30 AM

by globenewswire.com

positive

positive

Medigene to Present at Upcoming Scientific Conferences

Planegg/Martinsried, October 16, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Oct 2, 2024 3:00 PM

by globenewswire.com

neutral

neutral

Medigene will Present at ASGCT 2024 and Host R&D Event

Planegg/Martinsried, October 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Sep 25, 2024 9:00 AM

by globenewswire.com

positive

positive

Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021

Planegg/Martinsried, September 25, 2024 – Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the...

MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

May 13, 2024 11:12 AM

by marketscreener.com

mixed

mixed

Scibase : Presentation Board of directors AGM 2024

Presentation of the proposed board members to the Annual General Meeting on 13 May 2024 Jesper Høiland - born 1960, chairman Education:...

MDGEF MDG1.DE EPGNY EPGNF ECX.DE 0QGJ.L RDUS IFRX

Read more →
Published at

Jan 9, 2024 3:45 PM

by globenewswire.com

mixed

mixed

Global Botanical Drugs Market Size is Estimated to Reach USD 3,431.32 million in 2031, Growing at a CAGR of 39%: Straits Research

Europe's booming botanical drug market is expected to reach a whopping USD 1.1 billion by 2031, driven by high cancer rates and a surge in research on...

JAGX GWPRF GWPH 0IT7.L 001540.KQ MDGEF MDG1.DE 0QGJ.L

Read more →
Published at

Oct 26, 2023 9:00 PM

by globenewswire.com

mixed

mixed

Neoantigen Cancer Vaccine Market Size is Projected to Reach $1.38 billion by 2030: Straits Research

The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare...

ZIOP MDGEF MDG1.DE GNCA CVACN.MX CVAC ADXS 688315.SS 5CV.DE 4594.T 0QGJ.L VACC.OL VACC-ME.OL PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MRNA.MX MRNA MRKD.BA MRK.SN MRK.PA MRK.MX MRK M1RN34.SA LLY.MX LLY.DE LLY.BA LLY LILY34.SA BNTXN.MX BNTX AGEN 6MK.DE 0Q1G.L 0A45.L 0A3M.L OSE.PA GRTS 0RAD.L

Read more →
Published at

Jul 30, 2021 10:00 PM

by markets.businessinsider.com

negative

negative

Global Neoantigen Cancer Vaccine (Synthetic Long Peptide, Nucleic Acid, Dendritic Cell, Tumor Cell) Market Report 2021

DUBLIN, July 30, 2021 /PRNewswire/ -- The 'Global Neoantigen Cancer Vaccine Market, By Product, By Neoantigen Type, By Route of Administration, By...

ZIOP VACC.OL VACC-ME.OL PFED.BA PFECL.SN PFE.MX PFE.DE PFE OSE.PA MRNA.MX MRNA MRKD.BA MRK.SN MRK.PA MRK.MX MRK MDGEF MDG1.DE M1RN34.SA LLY.MX LLY.DE LLY.BA LLY LILY34.SA GRTS GNCA BNTXN.MX BNTX AGEN ADXS 6MK.DE 688315.SS 4594.T 0RAD.L 0QGJ.L 0Q1G.L 0A45.L 0A3M.L

Read more →
Published at

Jan 28, 2021 6:14 PM

by seekingalpha.com

negative

negative

Medigene pulls plug on MDG1021 development program (OTCMKTS:MDGEF)

Clinical stage immuno-oncology company Medigene AG (OTCPK:MDGEF) announces the discontinuation of its blood cancer treatment MDG1021's development program, as it looks to focus on the...

MDGEF MDG1.F MDG1.DE MDG1.BE

Read more →